These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20464807)

  • 1. Young adult Ecstasy users who forego necessary medical care: a fairly common occurrence with important health implications.
    Elifson KW; Klein H; Sterk CE
    J Psychoactive Drugs; 2010 Mar; 42(1):63-71. PubMed ID: 20464807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-esteem and HIV risk practices among young adult ecstasy users.
    Klein H; Elifson KW; Sterk CE
    J Psychoactive Drugs; 2010 Dec; 42(4):447-56. PubMed ID: 21305909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young adult Ecstasy users' enhancement of the effects of their Ecstasy use.
    Klein H; Elifson KW; Sterk CE
    J Psychoactive Drugs; 2009 Jun; 41(2):113-20. PubMed ID: 19705673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young adult Ecstasy users and multiple sexual partners: understanding the factors underlying this HIV risk practice.
    Sterk CE; Klein H; Elifson KW
    J Psychoactive Drugs; 2008 Sep; 40(3):237-44. PubMed ID: 19004415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are ecstasy users biased toward endorsing somatic mental health symptoms? Results from a general community sample.
    George AM; Windsor TD; Rodgers B
    Psychopharmacology (Berl); 2011 Apr; 214(4):901-9. PubMed ID: 21140259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding recreational ecstasy use in the United States: a qualitative inquiry.
    Bahora M; Sterk CE; Elifson KW
    Int J Drug Policy; 2009 Jan; 20(1):62-9. PubMed ID: 18068967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ecstasy and gateway drugs: initiating the use of ecstasy and other drugs.
    Reid LW; Elifson KW; Sterk CE
    Ann Epidemiol; 2007 Jan; 17(1):74-80. PubMed ID: 17140814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
    Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
    Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived risk associated with ecstasy use: a latent class analysis approach.
    Martins SS; Carlson RG; Alexandre PK; Falck RS
    Addict Behav; 2011 May; 36(5):551-4. PubMed ID: 21296504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecstasy use in Australia: patterns of use and associated harm.
    Topp L; Hando J; Dillon P; Roche A; Solowij N
    Drug Alcohol Depend; 1999 Jun; 55(1-2):105-15. PubMed ID: 10402155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting into ecstasy: comparing moderate and heavy young adult users.
    Sterk CE; Theall KP; Elifson KW
    J Psychoactive Drugs; 2007 Jun; 39(2):103-13. PubMed ID: 17703705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.
    George J; Kinner SA; Bruno R; Degenhardt L; Dunn M
    Drug Alcohol Rev; 2010 May; 29(3):243-9. PubMed ID: 20565515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tri-city study of Ecstasy use problems: a latent class analysis.
    Scheier LM; Ben Abdallah A; Inciardi JA; Copeland J; Cottler LB
    Drug Alcohol Depend; 2008 Dec; 98(3):249-63. PubMed ID: 18674872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, touch, and HIV risk among ecstasy users.
    Theall KP; Elifson KW; Sterk CE
    AIDS Behav; 2006 Mar; 10(2):169-78. PubMed ID: 16456728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.